SLXN
Silexion Therapeutics Corp Ordinary Shares
SLXN
SLXN
3 hedge funds and large institutions have $281K invested in Silexion Therapeutics Corp Ordinary Shares in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
–
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$29.9K |
| 2 |
HF
HRT Financial
New York
|
$23K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
$0 |
| 2 |
TSS
Two Sigma Securities
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WCM
1
Wildcat Capital Management
New York
| $228K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $29.9K | +$26.5K | +878 | +784% |
|
|
HF
3
HRT Financial
New York
| $23K | +$3.66K | +126 | +19% |
|
|
VF
4
Virtu Financial
New York
| – | -$14K | -197 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$7.94K | -112 | Closed |
|